loadpatents
Patent applications and USPTO patent grants for Hedrick; Joseph A..The latest application filed is for "anti-pcsk9 and methods for treating lipid and cholesterol disorders".
Patent | Date |
---|---|
Method of reducing total cholesterol level by administering matrilin-2 polypeptide Grant 9,089,522 - Zhang , et al. July 28, 2 | 2015-07-28 |
Anti-pcsk9 And Methods For Treating Lipid And Cholesterol Disorders App 20140161798 - Hedrick; Joseph A. ;   et al. | 2014-06-12 |
Anti-PCSK9 and methods for treating lipid and cholesterol disorders Grant 8,598,320 - Hedrick , et al. December 3, 2 | 2013-12-03 |
Egf-a Domain-mediated Modulation Of Pcks9 For Treating Lipid Disorders App 20110150875 - Zhang; Qing ;   et al. | 2011-06-23 |
Anti-pcsk9 And Methods For Treating Lipid And Cholesterol Disorders App 20110033465 - Hedrick; Joseph A. ;   et al. | 2011-02-10 |
Mammalian Chemokines; Receptors; Reagents; Uses App 20100068763 - Hedrick; Joseph A. ;   et al. | 2010-03-18 |
Anti-CCL27 antibodies Grant 7,601,815 - Vicari , et al. October 13, 2 | 2009-10-13 |
Histamine receptor Grant 7,547,523 - Behan , et al. June 16, 2 | 2009-06-16 |
Adenosine receptor Grant 7,465,789 - Hedrick , et al. December 16, 2 | 2008-12-16 |
Mammalian Chemokines; Receptors; Reagents; Uses App 20080107643 - Hedrick; Joseph A. ;   et al. | 2008-05-08 |
Dnaxccr10 Grant 7,307,146 - Hedrick , et al. December 11, 2 | 2007-12-11 |
Histamine Receptor App 20070117155 - Behan; Jiang X. ;   et al. | 2007-05-24 |
Adenosine Receptor App 20070112177 - Hedrick; Joseph A. ;   et al. | 2007-05-17 |
Mammalian cytokines; related reagents and methods Grant 7,205,381 - Hedrick , et al. April 17, 2 | 2007-04-17 |
Histamine receptor antibody Grant 7,166,705 - Behan , et al. January 23, 2 | 2007-01-23 |
Adenosine receptor Grant 7,157,244 - Hedrick , et al. January 2, 2 | 2007-01-02 |
Dnaxccr10 App 20060269993 - Hedrick; Joseph A. ;   et al. | 2006-11-30 |
CCL27 polypeptides Grant 7,101,987 - Vicari , et al. September 5, 2 | 2006-09-05 |
Histamine receptor App 20050074768 - Behan, Jiang X. ;   et al. | 2005-04-07 |
7 transmembrane receptor family member BLRx App 20040203080 - Hedrick, Joseph A. ;   et al. | 2004-10-14 |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications App 20040097482 - Davis, Harry R. ;   et al. | 2004-05-20 |
7 transmembrane receptor family member BLRX Grant 6,737,252 - Hedrick , et al. May 18, 2 | 2004-05-18 |
7 Transmembrane Receptor Family Member Blrx App 20030166052 - Hedrick, Joseph A. ;   et al. | 2003-09-04 |
Histamine receptor Grant 6,613,533 - Behan , et al. September 2, 2 | 2003-09-02 |
Mammalian chemokines; related reagents App 20030031646 - Vicari, Alain P. ;   et al. | 2003-02-13 |
Lymphotactin uses App 20030007970 - Hedrick, Joseph A. ;   et al. | 2003-01-09 |
Modulating Th2 cell levels via vMIP-I/CCR8 interaction App 20020172681 - Hedrick, Joseph A. | 2002-11-21 |
Mammalian cytokines; related reagents and methods App 20020164332 - Hedrick, Joseph A. ;   et al. | 2002-11-07 |
Adenosine receptor App 20020137887 - Hedrick, Joseph A. ;   et al. | 2002-09-26 |
Mammalian chemokines; receptors; reagents; uses App 20020103361 - Huffine, Constance F. ;   et al. | 2002-08-01 |
Histamine receptor App 20020098539 - Behan, Jiang X. ;   et al. | 2002-07-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.